Taking a chunk of Pfizer during this selloff, while Amazon has raised $10 billion in mixed-maturity debt and all eyes are on the government's response to civil unrest in the U.S.
When I first started buying ARCT shares I didn't conceive of a valuation of $1 billion, but I also didn't conceive of the global impact of a pandemic.
I've been long Merck for a long time, since way before this pandemic became part of our lives.
Let's check out a few charts on EVFM shares.
I would look for further sideways trading on ARWR.
Watching Moderna, Microsoft and FedEx as risk continues to be a central market theme, despite Monday's rally.
I'm long this name, as I am several of the others involved. Will I add on a day like this?
The current quarter, according to the analyst community, is understandably not shaping up as stellar.
The question is whether you want to buy before the breakout or after the breakout?
I have always liked the aggressive management.